Work

5 Phase 3 Randomized Controlled Trial of All-oral Treatment With Sofosbuvir + Ribavirin for 12 Weeks Compared to 24 Weeks of Peg + Ribavirin in Treatment-naïve Gt2/3 Hcv-infected Patients (fission)

Year: 2013

Type: article

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(13)60007-0

Authors: E. Gane, E. Lawitz, M. Rodriguez-Torres, S. Gordon, H. Dvory-Sobol, S. Arterburn, J. McNally, D.M. Brainard, W.T. Symonds, J.G. McHutchison, A. Sheikh, A. Mangia

Institutions: Auckland City Hospital, University of Florida, Toronto Western Hospital, Virginia Mason Medical Center, Henry Ford Health, Wayne State University, Casa Sollievo della Sofferenza, Gilead Sciences (United States), Duke Medical Center

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1988313061

FWCI: 2.218

Cites:

Cited by: 12

Related to: 10